Cheap version of HIV-prevention shot raising hope in low-income countries

The FDA's approval of a generic version of the only twice-a-year shot for HIV prevention signals a significant breakthrough, especially for low- and middle-income countries where access to healthcare can be a challenge. This cheaper alternative could vastly improve the ability to combat HIV in regions most affected, potentially reducing the spread and saving countless lives. With the drug now more affordable, it's expected to reach more people in need, marking a crucial step forward in global health efforts.